Skip to main content

Table 2 Patient baseline characteristics

From: Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir

    CK EBRT
# Evaluable patients    
  Total   43 75
# Follow up from end of RT   
   Thru Year 1 43 42
   Thru Year 2 38 62
   Thru Year 3 27 68
# with PSA follow-up for all 3 intervals 26 37
Median age at RT (yrs) (range) 69.0 (51 – 83) 69.8 (55 – 82)
Gleason score:     
  3 + 3   24 (56%) 59 (79%)
  3 + 4   19 (44%) 16 (21%)
Pretreatment PSA (ng/mL)    
  Median (range) 6.2 (2.0 – 13.5) 5.9 (0.1 – 16.7)
  # >10.0 ng/mL 10 (23%) 19 (25%)
Years of RT    2006 – 2011 1997 – 2006
Median follow-up (mos.) (range) 29.3 (12 – 75) 62.1 (15 – 156)